Chicago Equity Partners’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
Chicago Equity Partners's AMED Position: Q1 2020 in Review
Chicago Equity Partners held its Amedisys (AMED) position steady in Q1 2020 at 4,700 shares worth $863K. The position accounts for 0.09% of the portfolio, ranked #310.
Chicago Equity Partners first reported a position in AMED in Q2 2018 and has held it in 8 quarters since. The position peaked at $4.5M in Q4 2018. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.
- Chicago Equity Partners held 4,700 shares of Amedisys worth $863K as of Q1 2020.
- Chicago Equity Partners left its Amedisys share count unchanged in Q1 2020.
- Amedisys made up 0.09% of Chicago Equity Partners's portfolio in Q1 2020, its #310 holding.
- Chicago Equity Partners first reported a position in Amedisys in Q2 2018 and has held it in 8 quarters since.
- Chicago Equity Partners's Amedisys position peaked at $4.5M in Q4 2018.
- 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.
Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.